#41: The ISCHEMIA trial on optimal care for patients with stable coronary disease with Dr Judith Hochman

This feature requires the newest version of Flash. You can download it here.

Both cardiologists and patients grapple with the concept that fixing a blockage may not prolong life, as indicated by the results of the landmark COURAGE and BARI 2D trials and reflected by the limited effect these trials seem to have had on clinical practice.

The large ISCHEMIA trial, led by Dr Judith Hochman, seeks to build on the results of COURAGE and BARI 2D to answer the important question: what is the best treatment for patients with stable coronary disease?

Dr Hochman joins the show to discuss rationale and trial design and give information on how to become involved in the study.

For more information on ISCHEMIA, click here.

To contact the study organizers, click here.

Dr Hochman has no relevant financial disclosures.

For Dr Harrington's disclosures, click here.

See also:

• Huge ISCHEMIA trial to tackle unanswered COURAGE, BARI 2D questions

• Physicians still doing late PCI of occluded arteries in stable patients

• European perspectives on appropriate use of PCI

• New data show COURAGE findings are not being implemented

• Medical therapy takes COURAGE: No benefit of PCI over optimal drugs for preventing events in stable CAD

• Getting to the bottom of BARI 2D

• No mortality, CV-event differences between revascularization and medical therapy in diabetics: BARI 2D

Cite this: #41: The ISCHEMIA trial on optimal care for patients with stable coronary disease with Dr Judith Hochman - Medscape - Oct 06, 2011.